Clinical Trial Update: Efficacy of Rifaximin to Treat Diarrhea-predominant Irritable Bowel Syndrome

View source ↗

Summary

This clinical trial update reports on the efficacy of rifaximin for treating diarrhea-predominant irritable bowel syndrome (IBS-D).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome

Drugs mentioned

• XIFAXAN (rifaximin)

Snippet

Sponsor: First Affiliated Hospital, Sun Yat-Sen University | Conditions: Irritable Bowel Syndrome | Status: UNKNOWN